The accumulation of myeloid immunosuppressive cells (MDSCs) at the tumor site correlates with bad prognosis in different type of cancers (22) and it has been well-established that GM-CSF acts as driver for MDSC differentiation in tumors (12). The gene discussed is CSF2; the disease is cancer.